WELL

197.25

+1.76%↑

PLD

123.57

+0.72%↑

AMT

180.37

-1.7%↓

EQIX

776.76

-1.08%↓

SPG

181.03

-0.87%↓

WELL

197.25

+1.76%↑

PLD

123.57

+0.72%↑

AMT

180.37

-1.7%↓

EQIX

776.76

-1.08%↓

SPG

181.03

-0.87%↓

WELL

197.25

+1.76%↑

PLD

123.57

+0.72%↑

AMT

180.37

-1.7%↓

EQIX

776.76

-1.08%↓

SPG

181.03

-0.87%↓

WELL

197.25

+1.76%↑

PLD

123.57

+0.72%↑

AMT

180.37

-1.7%↓

EQIX

776.76

-1.08%↓

SPG

181.03

-0.87%↓

WELL

197.25

+1.76%↑

PLD

123.57

+0.72%↑

AMT

180.37

-1.7%↓

EQIX

776.76

-1.08%↓

SPG

181.03

-0.87%↓

Search

Kilroy Realty Corp

Slēgts

SektorsNekustamais īpašums

40.35 -1.15

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

40.14

Max

41.1

Galvenie mērījumi

By Trading Economics

Ienākumi

200M

156M

Pārdošana

-10M

280M

P/E

Sektora vidējais

15.613

80.017

EPS

0.38

Dividenžu ienesīgums

4.97

Peļņas marža

55.844

Darbinieki

229

EBITDA

-13M

168M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+6.21% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

4.97%

5.89%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

127M

5.1B

Iepriekšējā atvēršanas cena

41.5

Iepriekšējā slēgšanas cena

40.35

Ziņu noskaņojums

By Acuity

50%

50%

62 / 189 Rangs Real estate

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Kilroy Realty Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. nov. 18:59 UTC

Galvenie tirgus virzītāji

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

2025. g. 17. nov. 23:40 UTC

Tirgus saruna

Gold Consolidates Amid Mixed Signals -- Market Talk

2025. g. 17. nov. 23:34 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2025. g. 17. nov. 22:58 UTC

Tirgus saruna

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

2025. g. 17. nov. 22:46 UTC

Tirgus saruna

Risk Assets Set to Have a Strong 2026 -- Market Talk

2025. g. 17. nov. 22:06 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

2025. g. 17. nov. 22:02 UTC

Peļņas

Trip.com Group 3Q Rev $2.6B >TCOM

2025. g. 17. nov. 22:02 UTC

Peļņas

Trip.com Group 3Q Adj EPS $3.87 >TCOM

2025. g. 17. nov. 22:02 UTC

Peļņas

Trip.com Group 3Q EPS $4.02 >TCOM

2025. g. 17. nov. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 17. nov. 21:40 UTC

Peļņas

James Hardie Industries 2Q Adj EPS 26c >JHX

2025. g. 17. nov. 21:40 UTC

Peļņas

James Hardie Industries 2Q Loss/Shr 10c >JHX

2025. g. 17. nov. 21:39 UTC

Peļņas

James Hardie Industries 2Q Sales $1.29B >JHX

2025. g. 17. nov. 21:38 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025. g. 17. nov. 21:38 UTC

Peļņas

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

2025. g. 17. nov. 21:10 UTC

Peļņas

XP Inc. 3Q EPS BRL2.47 >XP

2025. g. 17. nov. 21:10 UTC

Peļņas

XP Inc. 3Q Rev BRL4.67B >XP

2025. g. 17. nov. 20:20 UTC

Tirgus saruna

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

2025. g. 17. nov. 20:12 UTC

Tirgus saruna

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

2025. g. 17. nov. 20:12 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. nov. 20:09 UTC

Tirgus saruna

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

2025. g. 17. nov. 19:29 UTC

Tirgus saruna

Gold Slide Continues to Start Week -- Market Talk

2025. g. 17. nov. 19:16 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025. g. 17. nov. 18:20 UTC

Iegādes, apvienošanās, pārņemšana

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

2025. g. 17. nov. 16:45 UTC

Iegādes, apvienošanās, pārņemšana

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

2025. g. 17. nov. 16:16 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025. g. 17. nov. 16:15 UTC

Peļņas

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

2025. g. 17. nov. 15:40 UTC

Iegādes, apvienošanās, pārņemšana

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

2025. g. 17. nov. 15:22 UTC

Iegādes, apvienošanās, pārņemšana

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

2025. g. 17. nov. 15:19 UTC

Tirgus saruna

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Salīdzinājums

Cenas izmaiņa

Kilroy Realty Corp Prognoze

Cenas mērķis

By TipRanks

6.21% augšup

Prognoze 12 mēnešiem

Vidējais 42.91 USD  6.21%

Augstākais 47 USD

Zemākais 33 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Kilroy Realty Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

12 ratings

2

Pirkt

8

Turēt

2

Pārdot

Tehniskais rādītājs

By Trading Central

30.81 / 32.73Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

62 / 189 Rangs Nekustamais īpašums

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Kilroy Realty Corp

Kilroy Realty Corporation (NYSE: KRC, the "Company", "Kilroy") is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust ("REIT") and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of June 30, 2024, Kilroy's stabilized portfolio totaled approximately 17.0 million square feet of primarily office and life science space that was 83.7% occupied and 85.4% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 92.8%. In addition, the Company had two in-process life science redevelopment projects totaling approximately 100,000 square feet with total estimated redevelopment costs of $80.0 million, and one approximately 875,000 square foot in-process development project with a total estimated investment of $1.0 billion.
help-icon Live chat